Elite Pharmaceuticals Inc (ELTP)

[bms65]

quote
"As discussed above, the science of abuse deterrence is relatively new. Both the technologies
involved and the analytical, clinical, and statistical methods for evaluating those technologies are
Contains Nonbinding Recommendations
26
rapidly evolving. For these reasons, FDA will take a flexible, adaptive approach to the
evaluation and labeling of potentially abuse-deterrent opioid products. Additionally, there is
considerable room for additional scientific work that could advance the development and
assessment of abuse-deterrent products. In particular, FDA encourages additional research on
the following topics"

pay attention to such words as "FDA is flexible" "the science of abuse deterrence is relatively new" .... any breakout in new tech or science = $$$$$$$$$$$$$$$$$$$$$$$$$$